Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy. | Cancers (Basel) | 2022 | 35205640 | PubTator, text mining | PubMed |
| Quercetin induces pannexin 1 expression via an alternative transcript with a translationally active 5' leader in rhabdomyosarcoma. | Oncogenesis | 2022 | 35194046 | PubTator, text mining | PubMed |
| Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review. | Cancer Med | 2022 | 35178869 | PubTator, text mining | PubMed |
| Patient-specific Boolean models of signalling networks guide personalised treatments. | Elife | 2022 | 35164900 | PubTator, text mining | PubMed |
| Prediction of transcription factors associated with DNA demethylation during human cellular development. | Chromosome Res | 2022 | 35142952 | PubTator, text mining | PubMed |
| Comparison of Tendon Development Versus Tendon Healing and Regeneration. | Front Cell Dev Biol | 2022 | 35141224 | PubTator, text mining | PubMed |
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics. | Cancer Lett | 2022 | 35122875 | PubTator, text mining | PubMed |
| HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression. | Cell Death Dis | 2022 | 35121725 | PubTator, text mining | PubMed |
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| Identification of functional tumor necrosis factor-alpha promoter variants associated with Helicobacter pylori infection in the Sudanese population: Computational approach. | World J Gastroenterol | 2022 | 35110948 | PubTator, text mining | PubMed |
| Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors. | Clin Cancer Res | 2022 | 35110417 | PubTator, text mining | PubMed |
| MethReg: estimating the regulatory potential of DNA methylation in gene transcription. | Nucleic Acids Res | 2022 | 35100398 | PubTator, text mining | PubMed |
| Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors. | Proc Natl Acad Sci U S A | 2022 | 35091470 | PubTator, text mining | PubMed |
| Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples. | Prostate | 2022 | 35084050 | PubTator, text mining | PubMed |
| Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections. | Nat Commun | 2022 | 35075135 | PubTator, text mining | PubMed |
| High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. | World J Surg Oncol | 2022 | 35065633 | PubTator, text mining | PubMed |
| Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment. | Curr Oncol Rep | 2022 | 35059992 | PubTator, text mining | PubMed |
| Challenges and Opportunities for the Translation of Single-Cell RNA Sequencing Technologies to Dermatology. | Life (Basel) | 2022 | 35054460 | PubTator, text mining | PubMed |
| Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers. | Cancers (Basel) | 2022 | 35053525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=33